At MNGI Digestive Health, patient well-being comes first. That promise is why the practice is not only a nationally ...

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be ...

A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than ...

A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified in almost all affected children through genetic testing.

Fox News senior correspondent Jonathan Serrie reports on doctors seeing results from Daraxonrasib, a new drug targeting ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Mike and Wes discuss the update on Micah Parsons' rehab (:42), rookie OL Jager Burton rotating in with the first team (9:25), WR Bo Melton's presence (12:24) and veteran LB Zaire Franklin's arrival ...

There’s a major medical breakthrough for pancreatic cancer - one of the deadliest cancers - which could double survival rates ...